Impact of the COVID-19 pandemic on antidepressant consumption in the Central region of Portugal: interrupted time series.

Impact of the COVID-19 pandemic on antidepressant consumption in the Central region of Portugal: interrupted time series.

Publication date: Jul 13, 2024

To evaluate the impact of the pandemic on the consumption of antidepressive agents in Central Portugal. To estimate the causal effect of the pandemic an interrupted time series analysis was conducted. Data of antidepressant drugs monthly dispensed in community pharmacies between Jan-2010 and Dec-2021 were provided by the regional Health Administration. Anti-Parkinson dopaminergic agents and statins, theoretically not influenced by COVID-19 pandemics, were used as comparator series. The number of packages was converted into defined daily doses and presented as defined daily doses/1000 inhabitants/day. A Bayesian structural time-series model with CausalImpact on R/RStudio was used to predict the counterfactual. Analyses with different geographical granularity (9 sub-regions and 78 municipalities) were performed. When compared to counterfactual, regional consumption non-significantly increased after the pandemic declaration, with a relative effect of + 1. 30% [95%CI -1. 6%:4. 2%]. When increasing the granularity, differences appeared between sub-region with significant increases in Baixo Mondego + 6. 5% [1. 4%:11. 0%], Guarda + 4. 4% [1. 1%:7. 7%] or Cova da Beira + 4. 1% [0. 17%:8. 3%], but non-significant variation in the remaining 6 sub-regions. Differences are more obvious at municipality level, ranging from increases of + 37. 00% [32. 00%:42. 00%] to decreases of -11. 00% [-17. 00%:-4. 20%]. Relative impact positively correlated with percentage of elderly in the municipality (r = 0. 301; p = 0. 007), and negatively with population density (r=-0. 243; p = 0. 032). No other predicting variables were found. Antidepressant consumption suffered very slight variations at regional level after the COVID-19 pandemic declaration. Analysis with higher granularity allowed identifying municipalities with higher impact (increase or decrease). The absence of clear association patterns suggests other causal hypotheses of the differences.

Open Access PDF

Concepts Keywords
Antidepressive Antidepressive agents
Bayesian COVID-19
Monthly Drug utilization
Parkinson Pharmacoepidemiology
Pharmacies

Semantics

Type Source Name
disease MESH COVID-19 pandemic
disease VO time
disease VO monthly
disease VO population
drug DRUGBANK Indoleacetic acid
disease MESH unemployment
drug DRUGBANK Ethanol
disease VO vaccination
disease MESH infectious diseases
drug DRUGBANK Serine
disease MESH suicidal ideation
disease MESH psychological distress
disease MESH anxiety disorder
disease MESH dementia
disease MESH psychiatric disorders
disease VO organization
drug DRUGBANK Timonacic
drug DRUGBANK Coenzyme M
disease IDO intervention
drug DRUGBANK Tretamine
disease IDO country
disease IDO process
drug DRUGBANK Pirlindole
disease VO dose
drug DRUGBANK Esomeprazole
drug DRUGBANK Hexocyclium
drug DRUGBANK Serotonin
drug DRUGBANK Pirenzepine
disease VO Equity
disease MESH loneliness
disease VO Canada
disease MESH post traumatic stress disorders
drug DRUGBANK Trestolone
disease MESH suicide
disease MESH Retirement
drug DRUGBANK Buprenorphine
drug DRUGBANK Benzodiazepine

Original Article

(Visited 1 times, 1 visits today)